FDA — authorised 19 December 2012
- Application: NDA021060
- Marketing authorisation holder: TERSERA
- Indication: Manufacturing (CMC)
- Status: approved
FDA authorised ZICONOTIDE ACETATE on 19 December 2012
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 19 December 2012.
TERSERA holds the US marketing authorisation.